Mitochondrial morphological dynamics affect the outcome of ischemic heart damage and pathogenesis. Recently, mitochondrial fission protein dynamin-related protein 1 (Drp1) has been identified as a mediator of mitochondrial morphological changes and cell death during cardiac ischemic injury. In this study, we report a unique relationship between Pim-1 activity and Drp1 regulation of mitochondrial morphology in cardiomyocytes challenged by ischemic stress. Transgenic hearts overexpressing cardiac Pim-1 display reduction of total Drp1 protein levels, increased phosphorylation of Drp1-
Mitochondrial morphological dynamics affect the outcome of ischemic heart damage and pathogenesis. Recently, mitochondrial fission protein dynamin-related protein 1 (Drp1) has been identified as a mediator of mitochondrial morphological changes and cell death during cardiac ischemic injury. In this study, we report a unique relationship between Pim-1 activity and Drp1 regulation of mitochondrial morphology in cardiomyocytes challenged by ischemic stress. Transgenic hearts overexpressing cardiac Pim-1 display reduction of total Drp1 protein levels, increased phosphorylation of Drp1-
S637
, and inhibition of Drp1 localization to the mitochondria. Consistent with these findings, adenoviral-induced Pim-1 neonatal rat cardiomyocytes (NRCMs) retain a reticular mitochondrial phenotype after simulated ischemia (sI) and decreased Drp1 mitochondrial sequestration. Interestingly, adenovirus Pimdominant negative NRCMs show increased expression of Bcl-2 homology 3 (BH3)-only protein p53 up-regulated modulator of apoptosis (PUMA), which has been previously shown to induce Drp1 accumulation at mitochondria and increase sensitivity to apoptotic stimuli. Overexpression of the p53 up-regulated modulator of apoptosis-dominant negative adenovirus attenuates localization of Drp1 to mitochondria in adenovirus Pim-dominant negative NRCMs promotes reticular mitochondrial morphology and inhibits cell death during sI. Therefore, Pim-1 activity prevents Drp1 compartmentalization to the mitochondria and preserves reticular mitochondrial morphology in response to sI.
I
schemic heart disease is a leading cause of death in the Western world. Many simultaneous cellular changes occur during cardiac ischemia and inevitably cause cell death. Mitochondria are especially sensitive to ischemic insult and trigger the initiation of apoptotic signaling (1) . Recently, mitochondrial morphological dynamics have been reported to play a role in ischemia/reperfusion injury (2, 3) . Mitochondria constantly undergo either fusion or fission and present either a reticular elongated or punctate fragmented phenotype, respectively (4, 5) . Prolonged simulated ischemic injury causes extensive fragmented mitochondrial morphology associated with dynamin-related protein 1 (Drp1) translocation to the mitochondria.
In mammalian cells, the profission protein Drp1 cycles between the cytosol and scission events on mitochondria, where it interacts with accessory proteins to couple GTP hydrolysis and outer mitochondrial membrane fission (6) . In addition to steadystate activity, Drp1 is also associated with early apoptosis (4, (7) (8) (9) (10) . Cellular stress increases Drp1 shuttling, which leads to fragmented mitochondrial networks, whereas prolonged or severe insult promotes stabilization of Drp1 to the mitochondria, which increases the likelihood of progression to apoptotic cell death (7, 8, (11) (12) (13) . Phosphorylation of Drp1-S637 prevents translocation to mitochondria, whereas overexpression of Drp1 K38A (a dominant-negative mutation lacking GTPase activity) prevents Drp1 translocation, attenuates a fragmented mitochondrial phenotype, and decreases cell death (4, 14) . Collectively, these observations suggest that Drp1 phosphorylation increases cell viability via inhibition of mitochondrial fission.
The serine/threonine kinase Pim-1 is a critical downstream effector of Akt-mediated cardioprotective signaling (15) (16) (17) (18) . Pim-1 is antiapoptotic and proproliferative, and recent findings indicate that it also exerts beneficial effects in part by preserving mitochondrial integrity (15) . Activation of Pim-1 in vitro and in mouse models of hypertrophy, infarction, and ischemia/reperfusion injury enhances cardiomyocyte survival through inhibition of intrinsic mitochondrial apoptotic pathways. The possibility that Pim-1 acts on Drp1 localization and activity has never been investigated in the context of ischemic cardiac injury. In this study, Pim-1 is shown to maintain mitochondrial networks by sequestration of Drp1 from the mitochondria after ischemic injury.
Results

Drp1
Localizes to the Mitochondria After Simulated Ischemia. Neonatal rat cardiomyocytes (NRCMs) displayed 70% reticular mitochondrial morphology in full media (Fig. 1A) . A time course of NRCMs treated with simulated ischemia (sI) demonstrated that mitochondrial fragmentation occurs quickly in response to an ischemic environment, transitioning from ∼30% of the cells displaying a fragmented phenotype to ∼90% by 30 min sI (Fig. 1A) . Fragmented mitochondrial morphology has been previously associated with sI, and DRP1
K38A was able to prevent this phenomenon, but cellular localization of endogenous Drp1 during sI was not evaluated (3). Fragmented mitochondrial morphology was consistent with Drp1 mitochondrial localization (Fig. 1B) , which persisted during simulated ischemia reperfusion (sI/R; Fig. 1C ). To confirm mitochondrial fragmentation was a result of Drp1 mitochondrial compartmentalization, Drp1 was inhibited by mdivi-1, a selective pharmacological inhibitor of Drp1 activity. Incubation of NRCMs with 50 μmol/L inhibitor mitochondrial division inhibitor-1 (mdivi-1) led to the formation of enlarged, globular mitochondria consistent with reports of Drp1 down-regulation (Fig. S1A) . Reticular mitochondria morphology was retained at a 2.5-fold higher level (P < 0.01) when NRCMs were treated with mdivi-1 during sI compared with DMSO-treated controls (Fig. S1B) , confirming that mitochondrial localization of Drp1 causes mitochondrial fragmentation. Prolonged Drp1 mitochondrial association is implicated in cell death, and sI/R injury in NRCMs caused a 3.54-fold increase in TUNEL-positive cells (Fig. S1C) . However, NRCMs incubated with mdivi-1 prevented sI/R-related cell death (Fig. S1C) .
Corroborating in vitro results of Drp1 localization after ischemic injury, in vivo ischemia/reperfusion injury resulted in Drp1 translocation to the mitochondria after 50 min ischemia and 15 min reperfusion by 2.3-fold (P < 0.01; Fig. 1D ). To augment these results by showing that mdivi-1 is effective in protecting the adult heart, age-and sex-matched mice were subjected to 50 min left anterior descending artery (LAD) ligation followed by 24 h reperfusion with and without mdivi-1 treatment. Total area at risk was similar between control and treatment groups, at 59% and 56%, respectively (Fig. S1F ). Phthalocyanine-blue dye and 2,3,5-triphenyltetrazolium chloride (TTC) staining indicated a smaller infarct size per area at risk in mice injected with mdivi-1, 0.61 ± 0.04 DMSO versus 0.43 ± 0.03 (P < 0.001) mdivi-1, showing that total infarct size decreased from 36% (DMSO) to 24% in mdivi-1-treated hearts (Fig. S1 D and E).
Drp1 Phosphorylation Is Regulated by Pim-1. Previous studies have shown that phosphorylation of Drp1-S637 reduces mitochondrial fragmentation, Drp1 accumulation at the mitochondria, and apoptotic cell death (19, 20) . Because we have established that Pim-1 kinase preserves mitochondrial integrity and function (15), we investigated whether Pim-1 expression could affect pDrp1-S637 levels. Hearts isolated from mice overexpressing cardiac Pim-1 (PimWT mice) displayed elevated levels of Drp1-S637 phosphorylation by 2.7-fold (P < 0.01; Fig. 2 A and B), and total Drp1 protein levels were reduced by 50% (P < 0.01) compared with nontransgenic controls (Fig. 2C) . In contrast, Pim-1-dominant negative (PDN) mice displayed a twofold decrease (P < 0.05) in phospho-Drp1 and a 1.63-fold increase (P < 0.05) in total Drp1 protein levels, suggesting that Pim-1 may influence Drp1 phosphorylation and total protein levels ( Fig. 2 D-F) . Furthermore, using fractionated heart lysates from PDN mice, immunoblot analysis revealed a 2.2-fold increase (P < 0.05) of Drp1 associated at the mitochondria compared with control ( Fig. 2 G and H).
Drp1 Translocation Is Regulated by Pim-1. Pim-1 preserves mitochondrial integrity, whereas mitochondria isolated from PDN mice show disrupted structural integrity upon calcium-induced swelling (15) . Therefore, we investigated the effect of Pim-1 on Drp1 localization. NRCMs transduced with an EGFP-Pim-1 (adPimWT) adenovirus were exposed to sI followed by subcellular fractionation. Immunoblot analysis revealed a twofold (P < 0.01) decrease in Drp1 expression in the mitochondrial compartment (Fig. 3A) , whereas total amounts of Drp1 protein decreased by 40% (P < 0.05) in Pim-1-infected NRCMs (Fig. S2A) . Furthermore, NRCMs overexpressing a kinase dead Pim-1 adenovirus, EGFP-PDN (adPDN), illustrate a 1.7-fold (P < 0.05) increase in Drp1 accumulation in the mitochondria fraction without being subjected to sI (Fig. 3B ). Whole-cell Drp1 protein levels were increased by 1.8-fold (P < 0.01; Fig. S2B ) in adPDN-treated NRCMs compared with EGFP, corroborating the in vivo results that loss of Pim-1 upregulates Drp1 protein levels.
Differences in Drp1 localization resulting from Pim-1 expression and sI were assessed in cytosolic and mitochondrial subcellular fractions. Drp1 expression was decreased at baseline conditions in adPimWT NRCM cytosol, whereas the mitochondrial fraction exhibited similar amounts of Drp1 (Fig. S2C) . Furthermore, Drp1 mitochondrial translocation upon sI was inhibited in adPimWT NRCMs relative to control samples (Fig. S2C) . Conversely, adPDN NRCMs displayed an increase in Drp1 expression within the cytosolic and mitochondrial fractions at baseline (Fig. S2D ). Drp1 shuttled into the mitochondria after sI treatment in both control as well as adPDN NRCMs, resulting in similar Drp1 expression in the mitochondrial fraction (Fig.  S2D) . Cycloheximide chase analysis demonstrated that Pim-1 does not alter Drp1 half-life (16 h) compared with EGFP control in NRCMs, demonstrating that Pim-1 does not target Drp1 degradation (Fig. S3) . Proteasome inhibition by MG132 caused an accumulation of Drp1 at 16 h in the presence of cycloheximide, validating Drp1 degradation through the proteasome (Fig. S3) .
To substantiate that Pim-1 prevents Drp1 translocation from the cytosol, mitochondrial morphology was assessed after sI on NRCMs transduced with adEGFP or adPimWT adenovirus. Before simulated ischemia, EGFP and PimWT NRCMs displayed 80% and 77% reticular mitochondrial morphology, respectively ( Fig. 3C and Fig. S4A ). However, after 15 min of sI treatment, 22% reticular mitochondria remained in EGFP NRCMs, whereas PimWT NRCMs retained 65% of their reticular morphology (P < 0.01; Fig. 3C ). At 30 min of sI, PimWT maintain 40% reticular mitochondria compared with 11% for EGFP (P < 0.05; Fig. 3C and Fig. S4A ). adPDN NRCMs basally express Drp1 at the mitochondria and display a striking 80% fragmented phenotype compared with EGFP control, suggesting that adPDN NRCMs may be more susceptible to cell death (P < 0.01; Fig. 3D and Fig. S4A ). Pim-1 overexpression in siDRPtreated NRCMs did not increase reticular mitochondrial morphology after sI, demonstrating the necessity of Drp1 for PimWT mitochondrial effects (Fig. S4B) .
PimWT mice and adPimWT NRCMs exhibited an increase in Drp1-S637 phosphorylation, thereby suggesting a potential site on Drp1 for Pim-1-mediated phosphorylation (Fig. 2B and Fig.  S2E ). Adenoviral overexpression of Drp1 in NRCMs, followed by immunoprecipitation of Pim-1, displayed Pim-1 and Drp1 association before and during sI treatment (Fig. 3E) , which was confirmed by proximity ligation assay in vitro (Fig. 3F) . Furthermore, phosphorylation of Drp1 by Pim-1 kinase is demonstrated by in vitro kinase assay (Fig. 3G) . Recombinant Drp1 was used as substrate, and γ- Mutation of serine 637 of Drp-1 to an alanine residue that cannot be phosphorylated (S637A) induces mitochondrial translocation of Drp-1 and fragmentation, whereas mutation to phosphomimetic aspartic acid (S637D) inhibits translocation (21) . The relevance of the serine 637 residue for Pim-1 mediated effects on Drp-1 subcellular localization and mitochondrial phenotype was assessed by coexpression of Drp1-S637A with either Pim-1-mCherry or mCherry alone as a control. Drp1-S637A localized to mitochondria and induced fragmentation when coexpressed with mCherry control ( Fig. S5 A and B) . Coexpression of Pim-1-mCherry together with Drp1-S637A appeared comparable to results observed using the mCherry control, supporting the postulate that inhibition of Drp-1 action by Pim-1 involves phosphorylation on serine 637 of Drp1 (Figs. 2 and S2E ). Drp1 Translocation Is Mediated by PUMA After Loss of Pim. The BH3-only protein p53 up-regulated modulator of apoptosis (PUMA) is reported to be required for Drp1 accumulation to the mitochondria in HeLa cells (22) . Proximity ligation assay (PLA) analysis with Drp1 and endogenous PUMA in NRCMs demonstrated protein-protein interaction at basal conditions (Fig. S6A) . PUMA protein levels decreased by 35% in PimWTtransgenic mice (P < 0.05; Fig. 4A ), and total PUMA expression decreased 50% after sI, as shown by immunoblot, suggesting that Pim-1 reduces Drp1 localization by inhibiting PUMA (P < 0.01; Fig. 4B ). In contrast, analysis of mitochondrial fractions from adEGFP and adPDN NRCMs showed a 2.2-fold increase in PUMA expression at the mitochondria mediated by PDN (P < 0.05; Fig. 4C ). Collectively, these results support the premise that inhibiting PUMA may rescue PDN-induced Drp1 localization to mitochondria and blunt fragmented mitochondrial morphology. To test this hypothesis, NRCMs were infected with adPDN alone or dually infected with adPDN and PUMA dominant-negative adenovirus (adPumaDN), a BH3 domain defective PUMA. PLA analysis in adPumaDN NRCMs with Drp1 exhibited interaction between the two proteins (Fig. S6B) . This result was confirmed by immunoprecipitation of adPumaDN NRCMs with Drp1 before and after sI, which also showed PumaDN and Drp1 interaction in vitro (Fig. S6C) . Immunoblot analysis after cell fractionation displayed a 1.7-fold increase in Drp1 mitochondrial and total Drp1 in murine PimWT and PDN whole-heart lysates. (G-H) Immunoblot of Drp1 localization in isolated mitochondria from PimDN (PDN) and FVB nontransgenic (NTG) control hearts harvested from ageand sex-matched mice. *P < 0.05; **P < 0.01; ***P < 0.001. translocation (P < 0.05) compared with EGFP control; however, overexpression of PumaDN significantly attenuates this accumulation by 2.4-fold (P < 0.01; Fig. 4D ).
Protein analysis of whole-cell lysates confirmed no change in total Drp1 protein levels, attributing the effect of PumaDN solely to localization of Drp1 (Fig. 4E) . To support PumaDN inhibition of Drp1 translocation, mitochondrial morphology was also evaluated after PumaDN rescue of the PDN-associated fragmented mitochondrial phenotype. Addition of PumaDN to NRCMs with PDN promoted a 60% reticular mitochondrial morphology compared with adPDN alone (Fig. 4F) . Extended Drp1 localization to the mitochondria can cause cell death; therefore, we assessed whether PumaDN could prevent apoptosis after sI. NRCMs infected with adPDN and subjected to 30 min sI resulted in 27% cell death compared with control (P < 0.05), whereas NRCMs dually infected with adPDN and adPumaDN displayed only 13% cell death (P < 0.001; Fig. 4G ).
Discussion
Mitochondria constantly undergo the process of fission and fusion, sustaining a homeostatic balance within the cell. Why mitochondria undergo fusion and fission is not well understood, but it is hypothesized that fission and fusion allow for complementation of mitochondrial mutations and elimination of dysfunctional mitochondria, thereby preserving functional mitochondrial populations (23) . Mitochondrial fission and fusion classically involve the participation of five individual proteins: Drp1, Mfn1, Mfn2, Fis1, and Opa1. Fusion involves the GTPase Opa1, Mfn1, and Mfn2, whereas Fis1 and Drp1 promote mitochondrial fission (2).
Disruption of mitochondrial morphological dynamics sensitizes cells to apoptotic cell death (9, 24, 25) , and recent studies have reported that disturbances within the balance of these two processes can implicate the outcome of cardiovascular disease and neurodegenerative disease (20) . In this study, we show that ischemic challenge in myocytes promotes translocation of Drp1 to p-ATP incorporation. His-Pim-1 (wild-type, kinase dead) was expressed in Escherichia coli and affinitypurified for use in the kinase assay. Phosphorylated proteins were separated by SDS/PAGE and visualized by autoradiography. *P < 0.05; **P < 0.01. the mitochondria, resulting in a fragmented mitochondrial phenotype ( Figs. 1 and 2) , and that Pim-1 kinase prevents these changes. Drp1 has been known to be associated with mitochondrial fission, and its persistent sequestration at the mitochondria is associated with cell death. The mechanism by which Drp1 causes fission is not completely understood.
In the past, Pim-1 has been shown to have multiple protective effects at the mitochondria (15, 26, 27) , but a relationship between Pim-1 and mitochondrial morphologic dynamics has not been examined previously. Pim-1 overexpression prevented Drp1 accumulation at mitochondria and decreased total Drp1 levels ( Fig. 3A and Fig. S2 A and C) . Conversely, the PDN mutant significantly increased total protein levels and mitochondrial Drp1 localization at baseline, but Drp1 translocation after sI did not increase relative to control samples ( Fig. 3B and Fig. S2 B and D) . Collectively, these findings support the postulate that Pim-1 inhibition of Drp1 translocation is the predominant mechanism of Drp1 regulation by Pim-1. Drp1 translocation was significantly reduced by Pim-1 overexpression during sI, and Drp1 accumulation at mitochondria is promoted by PDN under basal condition. Because mitochondria already display a fragmented phenotype during sI before reperfusion, small increases of mitochondrial Drp1 promote fragmented mitochondrial morphology.
Protein-protein interaction between Pim-1 and Drp1 occurs under both basal and ischemic conditions (Fig. 4E) , which is consistent with prior reports of Pim-1 binding to and stabilizing proteins (19) , raising the possibility that Pim-1 promotes Drp1 cytosolic sequestration by association. Drp1 mitochondrial shuttling is inhibited by phosphorylation at S 637 , with Drp1-S637 dephosphorylation modulated by calcineurin (21, 28) . Dephosphorylation of Drp1-S637 prevents cytosolic sequestration of Drp1 and promotes mitochondrial fission, which is consistent with our observation of increased levels of phospho-Drp1 in Pim-1 overexpressing transgenic hearts. Cell death analysis with propidium iodide of NRCMs subjected to simulated ischemia. *, significant compared with respective baseline control; #, significant compared with EGFP sI; $, significant compared with PDN sI. #P < 0.05; *P < 0.05; ##P < 0.01; $$P < 0.01; **P < 0.01; $$$P < 0.001; ***P < 0.001.
Although Drp1-S637 is a phosphorylation target for Pim-1, additional candidate residues on Drp1 are also likely phosphorylated to alter Drp1 function and localization, which will be assessed in future studies.
Drp1-mediated fission events primarily occur through multiple protein-protein interactions that form multimeric complexes (29) . It was recently reported that PUMA is necessary for Drp1 to accumulate at the mitochondria; however, a direct interaction between PUMA and Drp1 remained unexplored (22) .
Our findings suggest a pivotal role for PUMA and Drp1 mitochondrial localization. PUMA is an upstream activator of the apoptotic cell death pathway through the mitochondria and mediates the cell death response during ischemic injury (30) . Mechanistically, PUMA's proapoptotic activity is linked to sequestration of Bcl-2 and Bcl-xL that causes a displacement of Bax and/or Bak and activation of the proapoptotic functions of these proteins (31, 32) . A loss of Pim kinase activity promoted an increase of Drp1 at the mitochondria and a greater number of fragmented mitochondria; however, addition of PumaDN was able to rescue a fragmented mitochondrial phenotype. This suggests that PUMA may play a role during Drp1 scission events and that the BH3 domain of PUMA may be necessary for the proper functioning of either Drp1 assembly or GTPase activity.
Several lines of evidence support the cardioprotective activity of Pim-1, including enhanced regeneration of the myocardium after myocardial infarction and preservation of mitochondrial structure during cardiac challenge. In this study, we demonstrate an additional beneficial effect of Pim-1 on preventing mitochondrial fission through Drp1 cytosolic sequestration. Interference with mitochondrial structural dynamics can prevent apoptotic cell death, as the intrinsic pathway of apoptosis occurs at the mitochondria.
Collective findings of cardiac overexpression of Pim-1 offer an excellent solution to use Pim-1 as a therapeutic agent for the treatment and intervention of cardiac cell death.
Methods
Adenoviral Constructs, NRCM Culture, Transgenic Animals, and Animal Use. Generation of EGFP, EGFP-PDN, and EGFP-PimWT adenoviral constructs and PimWT and PDN transgenic mice was reported previously (15, 17, 18) . NRCM isolation and culture was performed as previously described (15, 18) . I/R surgery was performed on sex-matched FVB mice 12-14 wk of age; further details are provided in SI Methods.
sI/R and Mitochondrial Morphology Analysis. After adenoviral infection, sI or sI/ R treatments were done in glucose-free media with 5 mM sodium cyanide and 20 mM 2-deoxy-glucose. For sI/R, 10 mM glucose was added after sI treatment for indicated times. Cells were fixed then stained with Tom20 (Santa Cruz, 1:200), and mitochondrial fragmentation was qualified on a cell-to-cell basis, using a confocal microscope.
Statistical Analysis. Statistical analysis was performed using Student's t-test.
Comparison of more than two groups was performed by one-way ANOVA with Bonferroni's post hoc test or by two-way ANOVA. A P value of less than 0.05 was considered statistically significant. Error bars represent SEM. Significance indicators are *P < 0.05, **P < 0.01, and ***P < 0.001.
